Status:

COMPLETED

Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis

Lead Sponsor:

Hvidovre University Hospital

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

To investigate whether cyclosporine, added to methotrexate and steroid, increases the possibility of inflammatory management early in the disease; furthermore to investigate the possible steroid-spari...

Detailed Description

Design: Multicentre, prospective, randomised, double-blind study with parallel design. Selection of patients: Patients with recently diagnosed rheumatoid arthritis (less than 6 months of persistent s...

Eligibility Criteria

Inclusion

  • Synovitis in at least 2 joints.
  • Compliance with the ACR criteria for RA.
  • Duration of no more than 6 months (from the first anamnestic non-traumatic synovitis of at least 6 weeks' duration).
  • Informed consent.

Exclusion

  • Age less than 18 years or more than 75 years
  • Lack of co-operability.
  • Previous treatment with DMARD
  • Corticosteroid treatment during the preceding 4 weeks.
  • Contra indications for the treatments (awaiting the recommendations from Novartis)
  • Previous or present malignant or premalignant disease
  • Poorly regulated hypertension
  • Impaired renal function
  • Immuno defective diseases, including HIV
  • Cardiac or pulmonary insufficiency
  • Serious arteriosclerosis
  • Serious granulocytopenia or thrombocytopenia
  • Impaired liver function (liver enzymes more than twice the highest normal limit).
  • Alcohol consumption of more than 3 drinks a week.
  • Poorly controlled epilepsy
  • Lack of contraception in fertile patients
  • Pregnancy and lactation
  • Psoriasis
  • Poorly regulated diabetes
  • Anticoagulant treatment
  • Known allergy to the medicine
  • Medicamental interactions
  • Other inflammatory rheumatic diseases

Key Trial Info

Start Date :

October 1 1998

Trial Type :

INTERVENTIONAL

End Date :

November 1 2007

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT00209859

Start Date

October 1 1998

End Date

November 1 2007

Last Update

September 21 2005

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hvidovre University Hospital

Hvidovre, Denmark, 2650